US FDA approved drugs from 2015–June 2020: a perspective

P Bhutani, G Joshi, N Raja, N Bachhav… - Journal of Medicinal …, 2021 - ACS Publications
In the present work, we report compilation and analysis of 245 drugs, including small and
macromolecules approved by the US FDA from 2015 until June 2020. Nearly 29% of the …

[HTML][HTML] Prevalence of chronic obstructive pulmonary disease and chronic bronchitis in eight countries: a systematic review and meta-analysis

P Jarhyan, A Hutchinson, D Khaw… - Bulletin of the World …, 2022 - ncbi.nlm.nih.gov
Objective To estimate the prevalence of chronic obstructive pulmonary disease (COPD) and
chronic bronchitis in eight countries in South Asia through a systematic review and meta …

[HTML][HTML] The impact of air pollution on deaths, disease burden, and life expectancy across the states of India: the Global Burden of Disease Study 2017

K Balakrishnan, S Dey, T Gupta… - The Lancet Planetary …, 2019 - thelancet.com
Background Air pollution is a major planetary health risk, with India estimated to have some
of the worst levels globally. To inform action at subnational levels in India, we estimated the …

[HTML][HTML] Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

JB Soriano, PJ Kendrick, KR Paulson… - The Lancet …, 2020 - thelancet.com
Background Previous attempts to characterise the burden of chronic respiratory diseases
have focused only on specific disease conditions, such as chronic obstructive pulmonary …

[HTML][HTML] Predictions, role of interventions and effects of a historic national lockdown in India's response to the COVID-19 pandemic: data science call to arms

D Ray, M Salvatore, R Bhattacharyya… - Harvard data science …, 2020 - ncbi.nlm.nih.gov
With only 536 cases and 11 fatalities, India took the historic decision of a 21-day national
lockdown on March 25. The lockdown was first extended to May 3 soon after the analysis of …

Under-and over-diagnosis of COPD: a global perspective

T Ho, RP Cusack, N Chaudhary, I Satia, OP Kurmi - Breathe, 2019 - Eur Respiratory Soc
Globally, chronic obstructive pulmonary disease (COPD) is the fourth major cause of
mortality and morbidity and projected to rise to third within a decade as our efforts to prevent …

Prediction of pulmonary diseases with electronic nose using SVM and XGBoost

VA Binson, M Subramoniam, Y Sunny… - IEEE Sensors …, 2021 - ieeexplore.ieee.org
The volatile organic compounds (VOC) present in the exhaled breath can be used as the
biomarkers of certain diseases especially pulmonary diseases. A system and device are …

Strengthening primary health-care services to help prevent and control long-term (chronic) non-communicable diseases in low-and middle-income countries

M Haque, T Islam, NAA Rahman… - … and healthcare policy, 2020 - Taylor & Francis
The prevalence of long-term (chronic) non-communicable diseases (NCDs) is increasing
globally due to an ageing global population, urbanization, changes in lifestyles, and …

[HTML][HTML] Coswara: A respiratory sounds and symptoms dataset for remote screening of SARS-CoV-2 infection

D Bhattacharya, NK Sharma, D Dutta, SR Chetupalli… - Scientific Data, 2023 - nature.com
This paper presents the Coswara dataset, a dataset containing diverse set of respiratory
sounds and rich meta-data, recorded between April-2020 and February-2022 from 2635 …

Fixed dose drug combinations–are they pharmacoeconomically sound? Findings and implications especially for lower-and middle-income countries

B Godman, H McCabe, TD Leong… - Expert review of …, 2020 - Taylor & Francis
Introduction There are positive aspects regarding the prescribing of fixed dose combinations
(FDCs) versus prescribing the medicines separately. However, these have to be balanced …